Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way
- PMID: 28331693
- PMCID: PMC5351488
- DOI: 10.5152/tjbh.2015.1669
Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way
Abstract
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular properties. Traditional classification use morphology to divide tumors into separate categories with differing behavior and prognosis. However, there are limitations of traditional classification systems, and new molecular methods are expected to improve classification systems. Molecular subtypes of breast carcinomas have been characterized in the last 11 years, and have been studied extensively. Much of the information accumulated in recent years, and molecular taxonomy seems to be still developing and undergoing change. The main question is whether new molecular techniques such as gene expression profiling will be accepted as gold standard in determining breast cancer subtypes, and whether molecular classification is useful in specific subtypes of breast cancer as it is in ductal carcinoma (nonspecific type). In addition, critical review of the literature reveals major problems such as poor definition, lack of reproducibility and lack of quality control in current molecular techniques and classifications. Therefore, current molecular approaches are not yet used in routine clinical practice and treatment guidance since they are immature and can even lead to incorrect assessment.
Keywords: Breast cancer; immunohistochemistry; microarray gene expression; the molecular classification.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Figures
Similar articles
-
Molecular classification of breast carcinomas with particular emphasis on "basal-like" carcinoma: a critical review.J Biophotonics. 2012 Apr;5(4):345-66. doi: 10.1002/jbio.201100097. Epub 2012 Jan 9. J Biophotonics. 2012. PMID: 22232077 Review.
-
Molecular classification of breast cancer: is it time to pack up our microscopes?Pathology. 2011 Jan;43(1):1-8. doi: 10.1097/PAT.0b013e328341e0b5. Pathology. 2011. PMID: 21240058 Review.
-
Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?Hum Pathol. 2008 Apr;39(4):506-13. doi: 10.1016/j.humpath.2007.09.005. Epub 2008 Mar 4. Hum Pathol. 2008. PMID: 18289638
-
Mixture classification model based on clinical markers for breast cancer prognosis.Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14. Artif Intell Med. 2010. PMID: 20005686
-
Classifications and prognosis of breast cancer: from morphology to molecular taxonomy.Breast J. 2010 Sep-Oct;16 Suppl 1:S15-6. doi: 10.1111/j.1524-4741.2010.00995.x. Breast J. 2010. PMID: 21050300
Cited by
-
Expression Patterns of ER, PR, HER-2/neu and p53 in Association with Nottingham Tumour Grade in Breast Cancer Patients.Sultan Qaboos Univ Med J. 2023 Nov;23(4):526-533. doi: 10.18295/squmj.7.2023.044. Epub 2023 Nov 30. Sultan Qaboos Univ Med J. 2023. PMID: 38090235 Free PMC article.
-
Assessment of response of neoadjuvant chemotherapy in carcinoma breast patients by high-frequency ultrasound.J Family Med Prim Care. 2022 Aug;11(8):4717-4722. doi: 10.4103/jfmpc.jfmpc_2186_21. Epub 2022 Aug 30. J Family Med Prim Care. 2022. PMID: 36353032 Free PMC article.
-
Leveraging preclinical models of metastatic breast cancer.Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189163. doi: 10.1016/j.bbcan.2024.189163. Epub 2024 Jul 29. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39084494 Review.
-
Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer.ACS Pharmacol Transl Sci. 2023 Apr 21;6(5):671-682. doi: 10.1021/acsptsci.3c00044. eCollection 2023 May 12. ACS Pharmacol Transl Sci. 2023. PMID: 37200812 Free PMC article. Review.
-
Glutathione and Xanthine Metabolic Changes in Tamoxifen Resistant Breast Cancer Cell Lines are Mediated by Down-Regulation of GSS and XDH and Correlated to Poor Prognosis.J Cancer. 2024 May 30;15(13):4047-4058. doi: 10.7150/jca.96659. eCollection 2024. J Cancer. 2024. PMID: 38947399 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. http://dx.doi.org/10.3322/caac.20107. - DOI - PubMed
-
- Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56:37–47. - PubMed
-
- Ellis IO, Cornelisse CJ, Schnitt SJ, Sasco AJ, Sastre-Garau X, Kaaks R. Invasive breast carcinomas. In: Tavassoli FA, Devilee P, editors. WHO Classification of Tumours Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003. pp. 13–19.
-
- Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol. 2009;6:718–730. http://dx.doi.org/10.1038/nrclinonc.2009.166. - DOI - PubMed
-
- Buerger H, Otterbach F, Simon R, Schäfer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol. 1999;189:521–526. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources